One of the most promising cancer treatments is cell therapy. Extracorporeal cell therapies involve removing cells from the patient and sending them to a lab for treatment before reimplanting them into the patient. This is a high-risk supply chain process. German-based Camelot ITLab has created a blockchain solution.
“Since highly innovative extracorporeal cell therapies are often the last hope for many patients, there is no room for error in the entire process. That is why we have come up with a digital application that not only ensures maximum data-sharing and data-storage security, but also focuses on the patient,” said Dr. Josef Packowski, CEO of CAMELOT Consulting Group
The blockchain solution aims to make sure the right cells are returned to the right patients. According to the company, “all data transactions take place exclusively between verified participants and are immutably and consistently stored by means of encryption in the blockchain”.
This isn’t the only application Camelot envisages. They’ve created a Camelot Hypertrust Platform which is a permissioned blockchain solution. Any solution can use one of several blockchain architectures: Ethereum, Hyperledger, SAP’s Leonardo or MultiChain.
Apart from the blockchain itself, the solution includes the standard features you’d expect: the ability to integrate data, encryption, privacy, and distributed apps.
As a leading SAP solution provider it’s not surprising they offer strong SAP integration. Many sensitive enterprise solutions don’t store private data directly on the blockchain but instead a hash of the data. Camelot has created a ‘Trusted Computing Appliance’ which is an SAP HANA off-chain database for storing the private data off-chain.
The cancer solution is intriguing. The question is whether a life and death situation is a good area for relatively immature technology. Perhaps alternative solutions are too flawed.